Search clinical trials for: Mosunetuzumab Intravenous (IV)

Total 9269 results

Hoffmann-La Roche

Active, not recruiting

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Diffuse Large B-cell Lymphoma

United States, Israel, Spain, Korea, Republic of, Poland, Taiwan
Genentech, Inc.

Active, not recruiting

A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Lymphocytic Leukemia, Chronic | Lymphoma, Non Hodgkin

United States, Korea, Republic of, Australia, United Kingdom, Germany, Canada, Spain
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

B-cell Non-Hodgkin Lymphoma

United States, Canada, Belgium, Spain, United Kingdom
Hoffmann-La Roche

Active, not recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma

Follicular Lymphoma

United Kingdom, United States, China, France, Spain
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Mosunetuzumab in People With Follicular Lymphoma

Lymphoma | Follicular Lymphoma

United States
Genentech, Inc.

Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun)

Non-Hodgkin Lymphoma

United States, Puerto Rico
Suvankar Majumdar

Completed

A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease

Sickle Cell Disease

United States
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Poland, Ukraine, Georgia, Moldova, Republic of
M.D. Anderson Cancer Center
Genentech, Inc.

Withdrawn

A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Refractory B-cell Acute Lymphoblastic Leukemia

United States
Singapore General Hospital
Singapore Civil Defence Force

Completed

Intraosseous vs Intravenous Access for Cardiac Arrest Treatment

Cardiac Arrest

Singapore
Weill Medical College of Cornell University
Epizyme, Inc.; Genentech, Inc.

Recruiting

Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma

Follicular Lymphoma

United States
Takeda
Takeda Development Center Americas, Inc.

Active, not recruiting

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

Hunter Syndrome

United States, Germany, Malaysia, Philippines, Thailand, Dominican Republic, Serbia, Vietnam
Lazarski University
Poznan University of Medical Sciences; Wroclaw Medical University; Medical University...

Completed

Intravascular Access of COVID-19 Patient Under Personal Protective Equipment

Emergencies | Cardiac Arrest

Poland
Emory University

Completed

Glucose Measurement Using Microneedle Patches (GUMP)

Diabetes

United States
Hoffmann-La Roche

Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma

United States, Israel, Italy, Spain, United Kingdom
BioNTech SE
Genentech, Inc.

Recruiting

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Colorectal Cancer Stage II | Colorectal Cancer Stage III

United States, Spain, United Kingdom, Germany, Belgium, Sweden
The Hospital for Sick Children
The Physicians' Services Incorporated Foundation

Completed

Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis

Gastroenteritis | Dehydration

Canada
Washington University School of Medicine
Genentech, Inc.

Recruiting

Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Autologous Stem Cell Transplant-Eligible Patients With Relapsed/Refractory Aggressive B Cell Lymphoma

Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed B-Cell Lymphoma | Follicular Lymphoma Grade 3B

United States
Polpharma Biologics S.A.

Completed

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri® (Antelope)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Belarus, Ukraine, Georgia, Croatia, Moldova, Republic of, Poland, Serbia
Royal Brisbane and Women's Hospital

Unknown

Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change

Phlebitis

Australia
Tranzyme, Inc.
Norgine

Completed

Ulimorelin Study of Efficacy and Safety (ULISES 008)

Gastrointestinal Dysmotility

United States, France, Czech Republic, Bulgaria, Lithuania, Romania
MD Stem Cells

Recruiting

Stem Cell Ophthalmology Treatment Study II (SCOTS2)

Glaucoma | Age-Related Macular Degeneration | Macular Degeneration | Retinitis Pigmentosa | Leber Hereditary Optic Neuropathy | Optic Atrophy | Blindness | Optic Neuropathy | Vision, Low | Retinal Disease | Stargardt Disease | Maculopathy | Retinopathy | Optic Nerve Disease | Nonarteritic Ischemic Optic Neuropathy | Vision... and other conditions

United States, United Arab Emirates
MD Stem Cells

Recruiting

Neurologic Stem Cell Treatment Study (NEST)

Stroke | Nervous System Diseases | Diabetic Neuropathies | Neurodegenerative Diseases | Cognitive Impairment | Amyotrophic Lateral Sclerosis | Dementia | Neurological Disorders | Alzheimer Disease | ALS | Traumatic Brain Injury | Cerebral Infarction | Lewy Body Disease | Cerebral Hemorrhage | Frontotemporal Dementia | Progressive... and other conditions

United States, United Arab Emirates
AbbVie

Not yet recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Alnylam Pharmaceuticals

Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

TTR-mediated Amyloidosis

Portugal, Sweden, Brazil, United States, France, Spain, Germany
Polpharma Biologics S.A.

Not yet recruiting

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (UCESIVE)

Ulcerative Colitis
Washington University School of Medicine
Genentech, Inc.

Recruiting

Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma

B Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | Aggressive Lymphoma | Follicular Lymphoma Grade 3

United States
Bayside Health
Australian and New Zealand College of Anaesthetists

Completed

Limiting IV Chloride to Reduce AKI After Cardiac Surgery (LICRA)

Patients Undergoing Cardiothoracic Surgery

Australia
University of Edinburgh
NHS Lothian

Completed

Cardiovascular Effects of Apelin In Healthy Volunteers

Healthy

United Kingdom
Menzies School of Health Research
National Health and Medical Research Council, Australia; Wellcome Trust; University... and other collaborators

Completed

Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria

Malaria, Falciparum

Indonesia
Tranzyme, Inc.
Norgine

Completed

Ulimorelin Study of Efficacy and Safety (ULISES 007) (ULISES)

Gastrointestinal Dysmotility

United States, United Kingdom, Serbia, Italy, Romania, Hungary, Poland
Lazarski University
Poznan University of Medical Sciences; Wroclaw Medical University; Medical University...

Completed

Intravascular Access in Suspected/Confirmed COVID-19 Patient

Shock | Emergency Medicine | Cardiopulmonary Arrest

Poland
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Advanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | Stage A Adult Primary Liver Cancer (BCLC) | Stage B Adult Primary Liver Cancer (BCLC)

United States
Mt. Sinai Medical Center, Miami
Florida Heart Research Institute

Completed

Contrast Nephropathy and Nitrates (CoNaN)

Contrast Induced Nephropathy

United States
GlaxoSmithKline

Completed

A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

Asthma

United Kingdom
Samsung Medical Center

Completed

Pre-warmed Intravenous Fluids and Monitored Anesthesia Care

Hypothermia

Korea, Republic of
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension

Essential Hypertension

United States
University Health Network, Toronto

Not yet recruiting

Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients (INTACT-HIP)

Surgery | Hip-fracture
Hoffmann-La Roche

Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Spain, Australia, Germany, United States, Italy, United Kingdom, France
University of Colorado, Denver

Recruiting

Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response

Oxidative Stress | Cannabis Smoking

United States
REGENXBIO Inc.

Active, not recruiting

A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501

Homozygous Familial Hypercholesterolemia (HoFH)

United States, Canada, Netherlands
University Hospital Fattouma Bourguiba

Completed

Intravenous Cannulation In Children During Sevoflurane Induction

Child | Intravenous Cannulation | Sevoflurane Induction
Assistance Publique - Hôpitaux de Paris

Completed

Oral Versus Intravenous Rehydration for Prevention of Dehydration in Premature Babies, During the First Days of Life. (SROPREMA)

Enteral Nutrition | Low Birth Weight Infant

France
Longeveron Inc.

Withdrawn

Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial (SIRONA)

Endothelial Dysfunction | Metabolic Disease
Washington University School of Medicine
Genentech, Inc.; Institute for Follicular Lymphoma

Recruiting

Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma

Lymphoma, Follicular | Follicular Lymphoma

United States
Green Cross Corporation

Completed

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

Immune Thrombocytopenia

Korea, Republic of
The Center for Rheumatic Disease, Allergy, & Immunology
Grifols Therapeutics LLC

Completed

Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

Infections | IgG Deficiency

United States
Dartmouth-Hitchcock Medical Center

Completed

Neuraceq™ PET for Detection of Brain Changes in Young Athletes Post-concussion

Concussion, Brain

United States
National Institute of Neurological Disorders and...

Enrolling by invitation

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2

Neuroinflammation | Systemic Inflammation | Microvascular Thrombosis

United States
University of Colorado, Denver

Completed

Appetite Regulation in Older-Aged Obese Individuals

Obesity | Aging

United States

Search clinical trials for: Mosunetuzumab Intravenous (IV)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations